The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Gene Expression Signature With Independent Prognostic Significance in Epithelial Ovarian Cancer
Open accessAbstract
Purpose: Currently available clinical and molecular prognostic factors provide an imperfect assessment of prognosis for patients with epithelial ovarian cancer (EOC). In this study, we investigated whether tumor transcription profiling could be used as a prognostic tool in this disease. Methods: Tumor tissue from 68 patients was profiled with oligonucleotide microarrays. Samples were randomly split into training and validation sets. A three-step training procedure was used to discover a statistically significant Kaplan-Meier split in the training set. The resultant prognostic signature was then tested on an independent validation set for confirmation. Results: In the training set, a 115-gene signature referred to as the Ovarian Cancer Prognostic Profile (OCPP) was identified. When applied to the validation set, the OCPP distinguished between patients with unfavorable and favorable overall survival (median, 30 months v not yet reached, respectively; log-rank P = .004). The signature maintained independent prognostic value in multivariate analysis, controlling for other known prognostic factors such as age, stage, grade, and debulking status. The hazard ratio for death in the unfavorable OCPP group was 4.8 (P = .021 by Cox proportional hazards analysis). Conclusion: The OCPP is an independent prognostic determinant of outcome in EOC. The use of gene profiling may ultimately permit identification of EOC patients appropriate for investigational treatment approaches, based on a low likelihood of achieving prolonged survival with standard first-line platinum-based therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L., & Davidson, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340101 · Cited by 2,796
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Shipp, M. A., Ross, K. N., Tamayo, P., Weng, A. P., Kutok, J. L., Aguiar, R. C. T., Gaasenbeek, M., Angelo, M., Reich, M., Pinkus, G. S., et al. (2002) · Nature Medicine · doi:10.1038/nm0102-68 · Cited by 2,428
Prediction of central nervous system embryonal tumour outcome based on gene expression
Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y. H., Goumnerova, L. C., Black, P. M., Lau, C., et al. (2002) · Nature · doi:10.1038/415436a · Cited by 2,371
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Self-citationGene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025
Multiclass cancer diagnosis using tumor gene expression signatures
Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C.-H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J. P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211566398 · Cited by 2,023
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
Armstrong, S. A., Staunton, J. E., Silverman, L. B., Pieters, R., den Boer, M. L., Minden, M. D., Sallan, S. E., Lander, E. S., Golub, T. R., & Korsmeyer, S. J. (2002) · Nature Genetics · doi:10.1038/ng765 · Cited by 1,723
Klein, U., Tu, Y., Stolovitzky, G. A., Mattioli, M., Cattoretti, G., Husson, H., Freedman, A., Inghirami, G., Cro, L., Baldini, L., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1625 · Cited by 918
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., Joseph, M., Libermann, T. A., Treon, S. P., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202445099 · Cited by 741
Self-citationMitsiades, N., Mitsiades, C. S., Richardson, P. G., Poulaki, V., Tai, Y.-T., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., Joseph, M., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1768 · Cited by 697
Self-citationClinicopathologic Features of <EMPH TYPE="ITAL">BRCA</EMPH>-Linked and Sporadic Ovarian Cancer
Boyd, J. (2000) · JAMA · doi:10.1001/jama.283.17.2260 · Cited by 536
Self-citationMitsiades, C. S., Mitsiades, N. S., McMullan, C. J., Poulaki, V., Shringarpure, R., Hideshima, T., Akiyama, M., Chauhan, D., Munshi, N., Gu, X., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536759100 · Cited by 531
Self-citationComparison of statistical methods for classification of ovarian cancer using mass spectrometry data
Wu, B., Abbott, T., Fishman, D., McMurray, W., Mor, G., Stone, K., Ward, D., Williams, K., & Zhao, H. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg210 · Cited by 478
Improved survival in women with BRCA‐associated ovarian carcinoma
Cass, I., Baldwin, R. L., Varkey, T., Moslehi, R., Narod, S. A., & Karlan, B. Y. (2003) · Cancer · doi:10.1002/cncr.11310 · Cited by 433
Transcriptional analysis of the B cell germinal center reaction
Klein, U., Tu, Y., Stolovitzky, G. A., Keller, J. L., Haddad, J., Miljkovic, V., Cattoretti, G., Califano, A., & Dalla-Favera, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437996100 · Cited by 409
Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment
Ntzani, E. E., & Ioannidis, J. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14686-7 · Cited by 323
Expression profiling of epithelial plasticity in tumor progression
Jechlinger, M., Grunert, S., Tamir, I. H., Janda, E., Lüdemann, S., Waerner, T., Seither, P., Weith, A., Beug, H., & Kraut, N. (2003) · Oncogene · doi:10.1038/sj.onc.1206887 · Cited by 294
Cannistra, S. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292108 · Cited by 291
Self-citationE-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium
Auersperg, N., Pan, J., Grove, B. D., Peterson, T., Fisher, J., Maines-Bandiera, S., Somasiri, A., & Roskelley, C. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6249 · Cited by 254
Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling
Küppers, R., Klein, U., Schwering, I., Distler, V., Bräuninger, A., Cattoretti, G., Tu, Y., Stolovitzky, G. A., Califano, A., Hansmann, M.-L., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16624 · Cited by 243
N-Cadherin Expression in Human Prostate Carcinoma Cell Lines
Tran, N. L., Nagle, R. B., Cress, A. E., & Heimark, R. L. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65177-2 · Cited by 231
Vincent-Salomon, A., & Thiery, J. P. (2003) · Breast Cancer Research · doi:10.1186/bcr578 · Cited by 223
Henriksen, R., Funa, K., Wilander, E., Bäckström, T., Ridderheim, M., & Öberg, K. (1993) · PubMed · Cited by 219
Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors
David, Y. B. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.463 · Cited by 200
Epithelial Cell Plasticity in Development and Tumor Progression
Thiery, J. P., & Chopin, D. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006256219004 · Cited by 197
Analysis of gene expression microarrays for phenotype classification.
Califano, A., Stolovitzky, G. A., & Tu, Y. (2000) · PubMed · Cited by 184
Yokoyama, Y., Jones, D. S., Licence, D., Yanaihara, A., Hastings, J. M., Holland, C. M., Emoto, M., UMEMOTO, M., Sakamoto, T., Sato, S., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600701 · Cited by 152
Thant, A. A., Nawa, A., Kikkawa, F., Ichigotani, Y., Zhang, Y., Sein, T. T., Amin, A. R. M. R., & Hamaguchi, M. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1010921730952 · Cited by 146
BAX protein expression and clinical outcome in epithelial ovarian cancer.
Tai, Y., Lee, S., Niloff, E., Weisman, C., Ströbel, T., & Cannistra, S. A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2583 · Cited by 135
Self-citationShawver, L. K., Schwartz, D. P., Mann, E., et al. (1997) · PubMed · Cited by 131
Kuhn, W. C., Schmalfeldt, B., Reuning, U., Pache, L., Berger, U., Ulm, K., Harbeck, N., Späthe, K., Dettmar, P., Höfler, H., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690278 · Cited by 131
Sakamoto, M., Kondo, A., Kawasaki, K., Goto, T., Sakamoto, H., Miyake, K., Koyamatsu, Y., Akiya, T., Iwabuchi, H., Muroya, T., et al. (2001) · PubMed · Cited by 110
Chambers, S. K., Ivins, C. M., & Carcangiu, M. L. (1998) · International Journal of Cancer · Cited by 99
Ueda, M., Terai, Y., Kumagai, K., Ueki, K., Yamaguchi, H., Akise, D., & Ueki, M. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6229 · Cited by 53
Lepre, J., Rice, J. J., Tu, Y., & Stolovitzky, G. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth035 · Cited by 43
Protein β-turn prediction using nearest-neighbor method
Kim, S. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg368 · Cited by 43
Seki, N., Kodama, J., Hashimoto, I., Hongo, A., Yoshinouchi, M., & Kudo, T. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.2.305 · Cited by 35
Hsieh, C., Chen, C., Chou, C., Lai, K., Jeng, Y., Kuo, M., & Wei, L. (2004) · Journal of Biomedical Science · doi:10.1007/bf02256568 · Cited by 33
Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor.
Kodama, J., Hashimoto, I., Seki, N., Hongo, A., Yoshinouchi, M., Okuda, H., & Kudo, T. (2001) · PubMed · Cited by 31
Cited by
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Tothill, R. W., Tinker, A. V., George, J., Brown, R., Fox, S. B., Lade, S., Johnson, D. S., Trivett, M. K., Etemadmoghadam, D., Locandro, B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0196 · Cited by 1,467
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
Verhaak, R. G. W., Tamayo, P., Yang, J.-Y., Hubbard, D., Zhang, H., Creighton, C. J., Fereday, S., Lawrence, M., Carter, S. L., Mermel, C. H., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65833 · Cited by 569
Self-citationKonstantinopoulos, P. A., Spentzos, D., Karlan, B. Y., Taniguchi, T., Fountzilas, E., Francoeur, N., Levine, D. A., & Cannistra, S. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5719 · Cited by 483
Self-citationA Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
Bonome, T., Levine, D. A., Shih, J., Randonovich, M., Pise-Masison, C. A., Bogomolniy, F., Ozbun, L., Brady, J., Barrett, J. C., Boyd, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6595 · Cited by 439
Self-citationYang, Y., Han, L., Yuan, Y., Li, J., Hei, N., & Liang, H. (2014) · Nature Communications · doi:10.1038/ncomms4231 · Cited by 423
Metadata
- Authors
- Spentzos, D., Levine, D. A., Ramoni, M. F., Joseph, M., Gu, X., Boyd, J., Libermann, T. A., & Cannistra, S. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-12-01
- Volume
- 22
- Issue
- 23
- Pages
- 4700-4710
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2117058881
- Cited by
- 255
- References
- 43
- FWCI
- 17.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.